Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infections

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 3, 2008, Pages 370-372

  Varaiya, Ami ^a   Dogra, Jyotsana ^a   Kulkarni, Manasi ^a   Bhalekar, Pallavi ^a  

^a SL Raheja Hospital   (India)

Author keywords

Escherichia coli; Extended spectrum beta lactamase; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; CARBAPENEM; CEFTAZIDIME; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LOMEFLOXACIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETIC FOOT; DISK DIFFUSION; ESCHERICHIA COLI; FOOT ULCER; HUMAN; HUMAN TISSUE; INFECTION; ISOLATION PROCEDURE; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MORTALITY; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; SCREENING TEST; SEPTICEMIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; SEPSIS;

EID: 50149106157     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.42513     Document Type: Article

References (12)

1. Motta RN, Oliveira MM, Magalhaes PS, Dias AM, Aragao LP, Forti AC, et al. Plasmid mediated extended spectrum beta-lactamase producing strains of Enterobacteriacea isolated from diabetic foot infections in Brazilian diabetic centre. Braz J Infect Dis 2003;7:129-34.
2. Nathisuwan S, Burgess DS, Lewis JS 2nd. ESBLs: Epidemiology, detection and treatment. Pharmacotherapy 2001;21:920-8.
3. Babypadmini S, Appalaraju B. Extended-spectrum β -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae- prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4.
4. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection of beta lactamase in nosocomial gram-negative clinical isolates. Indian J Med Microbiol 2004;22:247-50.
5. Forbes BA, Sham DF, Weissfeld AS, editors. Overview of Conventional methods for bacterial identification. Chapter 13. In: Baliley and Scott's Diagnostic Microbiology, 10th ed. St. Louis: The CV Mosby Company; 1998. p. 167.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk tests; Approved Standards, 9th ed. CLSI Document M2- A9, Vol. 26 No 1. Wayne PA: 2006.
7. Mathur P, Tatman A, Das B, Dhavan B. Prevalence of ESBL gram negative bacteria in a tertiary care hospital. Indian J Med Microbiol 2002;115:153-7.
8. Babypadmini S, Appalaraju B. Extended-spectrum β -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae- prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4.
9. Ananthakrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum β-lactamase producers among surgical wound infections and burn patients in JIPMER. Indian J Med Microbiol 2004;18:160-5.
10. Kumar MS, Lakshmi V, Rajagopalan R. Occurrence of extended spectrum beta lactamases among Enterobacteriaceae spp. Isolated at a tertiary care institute. Indian J Med Microbiol 2006;24:208-11.
11. Kapil A, Dhawan B, Gadepalli R, Sreenivas V, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian Tertiary Care Hospital. Diabetes Care 2006;29:1727-32.
12. Chaudhary U, Aggarwal R. Extended spectrum beta lactamases: An emerging threat to clinical therapeutics. Indian J Med Microbiol 2004;22:75-80.